NASDAQ:HSGX

Histogenics Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

$7.56

+0.15 (+2.02 %)

(As of 06/23/2021 12:00 AM ET)

Add

Compare

Today's Range

$7.11

▼

$7.65

50-Day Range

$0.16

▼

$3.07

52-Week Range

$0.08

▼

$1.43

Volume26.81 million shs

Average Volume9.06 million shs

Market Capitalization$715.17 million

P/E RatioN/A

Dividend YieldN/A

Beta3.1

Receive HSGX News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogenics and its competitors with MarketBeat's FREE daily newsletter.

About Histogenics

Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.

ORTH.CN: New Board Members Bring Orthobiologics and Management Experience - Yahoo Finance
June 23, 2021 | finance.yahoo.com

Form DEF 14A BIODELIVERY SCIENCES For: Jun 22 - StreetInsider.com
June 23, 2021 | streetinsider.com

Form DEF 14A Ocugen, Inc. For: Jun 11 - StreetInsider.com
April 29, 2021 | streetinsider.com

Form DEF 14A Strongbridge Biopharma For: May 13 - StreetInsider.com
April 14, 2021 | streetinsider.com

Global Automated and Closed Cell Therapy Processing Systems Market Trends and Forecasts, 2020-2030: Cell Processing Steps, Scale of Operations, End Users and Geographical Regions - GlobeNewswire
April 1, 2021 | globenewswire.com

Ortho Regenerative Technologies Adds Patrick O'Donnell to Board of Directors - StreetInsider.com
February 24, 2021 | streetinsider.com

3 Dividend Stocks Perfect for Retirees - Nasdaq
February 16, 2021 | nasdaq.com

Is Ocugen a Buy After Doubling Last Week? - Motley Fool
February 15, 2021 | fool.com

Company News for Dec 23, 2020 - Yahoo Finance
December 23, 2020 | finance.yahoo.com

Ocugen (OCGN) Soars: Stock Adds 6.6% in Session - Nasdaq
December 2, 2020 | nasdaq.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HSGX
Previous Symbol
CUSIPN/A
CIK1372299
Webwww.histogenics.com
Phone781-547-7900
Employees49
Year FoundedN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book Value($0.01) per share
Price / Book-756.00

Profitability

EPS (Most Recent Fiscal Year)($0.79)
Net Income$-8,640,000.00
Net MarginsN/A
Return on Equity-34.96%
Return on Assets18.40%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares94,599,000
Market Cap$715.17 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.73 out of 5 stars

Medical Sector

1306th out of 2,105 stocks

Surgical Appliances & Supplies Industry

32nd out of 40 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Histogenics.

2.8 Community Rank

Outperform Votes
Histogenics has received 359 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Histogenics has received 284 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Histogenics has received 55.83% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Histogenics and other stocks. Vote “Outperform” if you believe HSGX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HSGX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Histogenics does not currently pay a dividend.
Dividend Growth
Histogenics does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Histogenics insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 19.70% of the stock of Histogenics is held by insiders.
Percentage Held by Institutions
40.35% of the stock of Histogenics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Histogenics is -9.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Histogenics is -9.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Histogenics (NASDAQ:HSGX) Frequently Asked Questions

What stocks does MarketBeat like better than Histogenics?

Wall Street analysts have given Histogenics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Histogenics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Histogenics' earnings last quarter?

Histogenics Corp (NASDAQ:HSGX) issued its quarterly earnings data on Thursday, August, 9th. The biotechnology company reported ($0.13) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.23) by $0.10.
View Histogenics' earnings history.

Who are Histogenics' key executives?

Histogenics' management team includes the following people:

Mr. Adam D. Gridley, Interim Pres, CEO Treasurer, Sec., Consultant & Director (Age 47)
Mr. Jonathan I. Lieber, Interim Chief Financial Officer (Age 49)
Mr. Stephen R. Kennedy, Consultant (Age 62)

Who are some of Histogenics' key competitors?

Some companies that are related to Histogenics include Establishment Labs (ESTA), Avanos Medical (AVNS), Inogen (INGN), Eargo (EAR), Sientra (SIEN), Invacare (IVC), Sanara MedTech (SMTI), United Health Products (UEEC), Conformis (CFMS), Lakeland Industries (LAKE), Surgalign (SRGA), Milestone Scientific (MLSS), CollPlant Biotechnologies (CLGN), Alpha Pro Tech (APT) and Nutriband (NTRB).
View all of HSGX's competitors.

What other stocks do shareholders of Histogenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Histogenics investors own include Interpace Biosciences (IDXG), Novavax (NVAX), Verastem (VSTM), Progenics Pharmaceuticals (PGNX), SCYNEXIS (SCYX), Magnegas Applied Tchnlgy Sltns (MNGA), Ocular Therapeutix (OCUL), Trevena (TRVN), OPKO Health (OPK) and Synergy Pharmaceuticals (SGYP).

When did Histogenics IPO?

(HSGX) raised $60 million in an IPO on Wednesday, December 3rd 2014. The company issued 4,300,000 shares at $13.00-$15.00 per share. Cowen and Company, Needham & Company and Canaccord Genuity acted as the underwriters for the IPO and BTIG was co-manager.

What is Histogenics' stock symbol?

Histogenics trades on the NASDAQ under the ticker symbol "HSGX."

What is Histogenics' stock price today?

One share of HSGX stock can currently be purchased for approximately $7.56.

How much money does Histogenics make?

Histogenics has a market capitalization of $715.17 million. The biotechnology company earns $-8,640,000.00 in net income (profit) each year or ($0.79) on an earnings per share basis.

How many employees does Histogenics have?

Histogenics employs 49 workers across the globe.

What is Histogenics' official website?

The official website for Histogenics is www.histogenics.com.

Where are Histogenics' headquarters?

Histogenics is headquartered at 830 WINTER STREET 3RD FLOOR, WALTHAM MA, 02451.

How can I contact Histogenics?

Histogenics' mailing address is 830 WINTER STREET 3RD FLOOR, WALTHAM MA, 02451. The biotechnology company can be reached via phone at 781-547-7900 or via email at [email protected]

This page was last updated on 6/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Histogenics Stock Forecast, Price & News

About Histogenics

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

2.8 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

0.8 Company Ownership

0.0 Earnings and Valuation

Histogenics (NASDAQ:HSGX) Frequently Asked Questions

What stocks does MarketBeat like better than Histogenics?

How were Histogenics' earnings last quarter?

Who are Histogenics' key executives?

Who are some of Histogenics' key competitors?

What other stocks do shareholders of Histogenics own?

When did Histogenics IPO?

What is Histogenics' stock symbol?

What is Histogenics' stock price today?

How much money does Histogenics make?

How many employees does Histogenics have?

What is Histogenics' official website?

Where are Histogenics' headquarters?

How can I contact Histogenics?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™